• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核因子-κB通路及其抑制剂:阿尔茨海默病治疗中的一个有前景的前沿领域。

NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer's Disease.

作者信息

Sivamaruthi Bhagavathi Sundaram, Raghani Neha, Chorawala Mehul, Bhattacharya Sankha, Prajapati Bhupendra G, Elossaily Gehan M, Chaiyasut Chaiyavat

机构信息

Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand.

Innovation Center for Holistic Health, Nutraceuticals, and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.

出版信息

Biomedicines. 2023 Sep 21;11(9):2587. doi: 10.3390/biomedicines11092587.

DOI:10.3390/biomedicines11092587
PMID:37761028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10526355/
Abstract

The nuclear factor kappa B (NF-κB) pathway has emerged as a pivotal player in the pathogenesis of various diseases, including neurodegenerative illnesses like Alzheimer's disease (AD). The involvement of the NF-κB pathway in immune system responses, inflammation, oxidative stress, and neuronal survival highlights its significance in AD progression. We discuss the advantages of NF-κB pathway inhibition, including the potential to mitigate neuroinflammation, modulate amyloid beta (Aβ) production, and promote neuronal survival. However, we also acknowledge the limitations and challenges associated with this approach. Balancing the fine line between dampening inflammation and preserving physiological immune responses is critical to avoid unintended consequences. This review combines current knowledge on the NF-κB pathway's intricate involvement in AD pathogenesis, emphasizing its potential as a therapeutic target. By evaluating both advantages and limitations, we provide a holistic view of the feasibility and challenges of NF-κB pathway modulation in AD treatment. As the quest for effective AD therapies continues, an in-depth understanding of the NF-κB pathway's multifaceted roles will guide the development of targeted interventions with the potential to improve AD management.

摘要

核因子κB(NF-κB)信号通路已成为包括阿尔茨海默病(AD)等神经退行性疾病发病机制中的关键因素。NF-κB信号通路参与免疫系统反应、炎症、氧化应激和神经元存活,凸显了其在AD进展中的重要性。我们讨论了抑制NF-κB信号通路的优势,包括减轻神经炎症、调节β-淀粉样蛋白(Aβ)生成以及促进神经元存活的潜力。然而,我们也认识到这种方法存在的局限性和挑战。在减轻炎症和维持生理免疫反应之间找到平衡对于避免意外后果至关重要。本综述结合了当前关于NF-κB信号通路在AD发病机制中复杂作用的知识,强调了其作为治疗靶点的潜力。通过评估优势和局限性,我们全面审视了在AD治疗中调节NF-κB信号通路的可行性和挑战。随着对有效AD治疗方法的探索不断深入,深入了解NF-κB信号通路的多方面作用将指导有潜力改善AD治疗的靶向干预措施的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a46/10526355/c1b1f345c967/biomedicines-11-02587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a46/10526355/c1b1f345c967/biomedicines-11-02587-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a46/10526355/c1b1f345c967/biomedicines-11-02587-g001.jpg

相似文献

1
NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer's Disease.核因子-κB通路及其抑制剂:阿尔茨海默病治疗中的一个有前景的前沿领域。
Biomedicines. 2023 Sep 21;11(9):2587. doi: 10.3390/biomedicines11092587.
2
Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.核因子-κB 轻链增强子的 B 细胞(NF-κB)-在神经退行性级联反应和阿尔茨海默病发病机制中的朋友、敌人还是旁观者。
CNS Neurol Disord Drug Targets. 2017;16(10):1050-1065. doi: 10.2174/1871527316666170725114652.
3
The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer's Disease.NF-κB 在阿尔茨海默病发病机制和治疗中的关键作用。
Int J Mol Sci. 2022 Aug 11;23(16):8972. doi: 10.3390/ijms23168972.
4
UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS.揭示 NF-ΚB 在阿尔茨海默病中的复杂作用:大脑炎症与潜在治疗靶点的新见解。
Georgian Med News. 2023 Sep(342):133-141.
5
Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease.植物化学物质作为 NF-κB 的抑制剂用于治疗老年痴呆症。
Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.
6
Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.多酚通过抑制 NF-κB 发挥神经抗炎作用以阻止阿尔茨海默病。
Curr Pharm Des. 2021;27(3):402-414. doi: 10.2174/1381612826666201118092422.
7
Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective.从神经炎症和氧化应激角度看星形胶质细胞在阿尔茨海默病中的作用
Front Mol Neurosci. 2017 Dec 19;10:427. doi: 10.3389/fnmol.2017.00427. eCollection 2017.
8
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.小胶质细胞中 NF-κB 和 P2X7/NLRP3/Caspase-1 通路的抑制剂:神经炎症诱导的早期阿尔茨海默病的新治疗机会。
J Neuroimmunol. 2019 Jan 15;326:62-74. doi: 10.1016/j.jneuroim.2018.11.010. Epub 2018 Nov 20.
9
Isoorientin Inhibits Amyloid β-Induced Neuronal Inflammation in BV2 Cells by Blocking the NF-κB Signaling Pathway.异土木香内酯通过阻断 NF-κB 信号通路抑制 Aβ诱导的 BV2 细胞神经炎症。
Molecules. 2021 Nov 22;26(22):7056. doi: 10.3390/molecules26227056.
10
Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.核因子κB作为阿尔茨海默病和多发性硬化症神经退行性病变关键治疗靶点的意义。
Expert Opin Ther Targets. 2015 Apr;19(4):471-87. doi: 10.1517/14728222.2014.989834. Epub 2015 Feb 4.

引用本文的文献

1
Histone Deacetylase 2 in Alzheimer's Disease: A Comprehensive Molecular Blueprint for Therapeutic Targeting.阿尔茨海默病中的组蛋白去乙酰化酶2:治疗靶点的全面分子蓝图
Mol Neurobiol. 2025 Aug 8. doi: 10.1007/s12035-025-05264-y.
2
Bridging the molecular and clinical aspects of resveratrol in Alzheimer's disease: a review.白藜芦醇在阿尔茨海默病中的分子与临床联系:综述
3 Biotech. 2025 Sep;15(9):284. doi: 10.1007/s13205-025-04451-x. Epub 2025 Aug 6.
3
Melatonin-A Powerful Antioxidant in Neurodegenerative Diseases.褪黑素——神经退行性疾病中的一种强大抗氧化剂。

本文引用的文献

1
Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.通过纳米结构脂质载体将多奈哌齐与虾青素联合递送至大鼠阿尔茨海默病模型的脑内。
Int J Nanomedicine. 2023 Jul 27;18:4193-4227. doi: 10.2147/IJN.S417928. eCollection 2023.
2
Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer's disease patient lymphocytes.西木菲兰可抑制阿尔茨海默病患者淋巴细胞中过度活跃的mTOR,并恢复其对胰岛素的敏感性。
Front Aging. 2023 Jun 29;4:1175601. doi: 10.3389/fragi.2023.1175601. eCollection 2023.
3
Micheliolide attenuates neuroinflammation to improve cognitive impairment of Alzheimer's disease by inhibiting NF-κB and PI3K/Akt signaling pathways.
Antioxidants (Basel). 2025 Jul 3;14(7):819. doi: 10.3390/antiox14070819.
4
Fermented Soybean Pulp Alleviates Disease Progression of 5×FAD Model Mice.发酵豆渣缓解5×FAD模型小鼠的疾病进展。
Mol Neurobiol. 2025 Jul 15. doi: 10.1007/s12035-025-05191-y.
5
Ergolide Regulates Microglial Activation and Inflammatory-Mediated Dysfunction: A Role for the Cysteinyl Leukotriene Pathway.麦角酰二乙胺调节小胶质细胞活化和炎症介导的功能障碍:半胱氨酰白三烯途径的作用
Int J Mol Sci. 2025 May 23;26(11):5050. doi: 10.3390/ijms26115050.
6
Role and Functions of Irisin: A Perspective on Recent Developments and Neurodegenerative Diseases.鸢尾素的作用与功能:近期进展及神经退行性疾病视角
Antioxidants (Basel). 2025 May 7;14(5):554. doi: 10.3390/antiox14050554.
7
Signaling Pathways in Oxidative Stress-Induced Neurodegenerative Diseases: A Review of Phytochemical Therapeutic Interventions.氧化应激诱导的神经退行性疾病中的信号通路:植物化学治疗干预综述
Antioxidants (Basel). 2025 Apr 12;14(4):457. doi: 10.3390/antiox14040457.
8
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer's Disease.微小RNA对细胞凋亡途径的调控:一种治疗阿尔茨海默病的策略。
Mol Neurobiol. 2025 Apr 12. doi: 10.1007/s12035-025-04833-5.
9
Molecular mechanisms and signaling pathways related to brain metastasis in breast cancer.与乳腺癌脑转移相关的分子机制和信号通路
Front Pharmacol. 2025 Mar 27;16:1585668. doi: 10.3389/fphar.2025.1585668. eCollection 2025.
10
Multi-target approach to Alzheimer's disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms.阿尔茨海默病预防与治疗的多靶点方法:抗氧化、抗炎和淀粉样蛋白调节机制。
Neurogenetics. 2025 Apr 1;26(1):39. doi: 10.1007/s10048-025-00821-y.
米氏内酯通过抑制NF-κB和PI3K/Akt信号通路减轻神经炎症,从而改善阿尔茨海默病的认知障碍。
Heliyon. 2023 Jul 4;9(7):e17848. doi: 10.1016/j.heliyon.2023.e17848. eCollection 2023 Jul.
4
[Mechanisms of moxibustion preconditioning underlying improving learning-memory ability by regulating polarization of microglia via TLR4/NF-κB signaling pathway in AD rats].[艾灸预处理通过TLR4/NF-κB信号通路调节小胶质细胞极化改善AD大鼠学习记忆能力的机制]
Zhen Ci Yan Jiu. 2023 Jun 25;48(6):525-32. doi: 10.13702/j.1000-0607.20220420.
5
Therapeutic potential of stem cells and acitretin on inflammatory signaling pathway-associated genes regulated by miRNAs 146a and 155 in AD-like rats.干细胞和阿维 A 酯通过 miRNA146a 和 155 调节的 AD 样大鼠炎症信号通路相关基因的治疗潜力。
Sci Rep. 2023 Jun 13;13(1):9613. doi: 10.1038/s41598-023-36772-3.
6
Prolactin-induced neuroprotection against excitotoxicity is mediated via PI3K/AKT and GSK3β/NF-κB in primary cultures of hippocampal neurons.在原代培养的海马神经元中,催乳素诱导的针对兴奋性毒性的神经保护作用是通过PI3K/AKT和GSK3β/NF-κB介导的。
Peptides. 2023 Aug;166:171037. doi: 10.1016/j.peptides.2023.171037. Epub 2023 Jun 8.
7
Citropten Ameliorates Osteoclastogenesis Related to MAPK and PLCγ/Ca Signaling Pathways through the Regulation of Amyloid Beta.西维来司他钠通过调节淀粉样蛋白β改善与 MAPK 和 PLCγ/Ca 信号通路相关的破骨细胞生成。
J Agric Food Chem. 2023 Jul 5;71(26):10037-10049. doi: 10.1021/acs.jafc.3c00368. Epub 2023 Jun 1.
8
Diversified cassane family diterpenoids from the leaves of Caesalpinia minax exerting anti-neuroinflammatory activity through suppressing MAPK and NF-κB pathways in BV-2 microglia.密花豆叶中具有多种结构的贝壳杉烷二萜类化合物通过抑制 BV-2 小胶质细胞中 MAPK 和 NF-κB 通路发挥抗神经炎症活性。
J Ethnopharmacol. 2023 Oct 28;315:116653. doi: 10.1016/j.jep.2023.116653. Epub 2023 May 24.
9
Molecular mechanisms and therapeutic potential of icariin in the treatment of Alzheimer's disease.淫羊藿苷治疗阿尔茨海默病的分子机制及治疗潜力。
Phytomedicine. 2023 Jul 25;116:154890. doi: 10.1016/j.phymed.2023.154890. Epub 2023 May 20.
10
Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.靶向谷氨酰胺酶的药物重定位揭示了治疗阿尔茨海默病患者的药物候选物。
J Transl Med. 2023 May 20;21(1):332. doi: 10.1186/s12967-023-04192-6.